JP2007509946A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007509946A5 JP2007509946A5 JP2006538169A JP2006538169A JP2007509946A5 JP 2007509946 A5 JP2007509946 A5 JP 2007509946A5 JP 2006538169 A JP2006538169 A JP 2006538169A JP 2006538169 A JP2006538169 A JP 2006538169A JP 2007509946 A5 JP2007509946 A5 JP 2007509946A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutical composition
- acid
- methylenebis
- phenoxyisobutyric
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 15
- 239000008194 pharmaceutical composition Substances 0.000 claims 12
- KGRVJHAUYBGFFP-UHFFFAOYSA-N 2,2'-Methylenebis(4-methyl-6-tert-butylphenol) Chemical compound CC(C)(C)C1=CC(C)=CC(CC=2C(=C(C=C(C)C=2)C(C)(C)C)O)=C1O KGRVJHAUYBGFFP-UHFFFAOYSA-N 0.000 claims 5
- -1 2-chlorophenyl ureido phenoxy Chemical group 0.000 claims 5
- ILPUOPPYSQEBNJ-UHFFFAOYSA-N 2-methyl-2-phenoxypropanoic acid Chemical compound OC(=O)C(C)(C)OC1=CC=CC=C1 ILPUOPPYSQEBNJ-UHFFFAOYSA-N 0.000 claims 5
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims 3
- JVXXKQIRGQDWOJ-UHFFFAOYSA-N naphthalene-2-carboxamide Chemical compound C1=CC=CC2=CC(C(=O)N)=CC=C21 JVXXKQIRGQDWOJ-UHFFFAOYSA-N 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 241000124008 Mammalia Species 0.000 claims 2
- 150000002632 lipids Chemical class 0.000 claims 2
- 235000019260 propionic acid Nutrition 0.000 claims 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims 2
- 208000002972 Hepatolenticular Degeneration Diseases 0.000 claims 1
- 208000008948 Menkes Kinky Hair Syndrome Diseases 0.000 claims 1
- 208000012583 Menkes disease Diseases 0.000 claims 1
- 208000018839 Wilson disease Diseases 0.000 claims 1
- 210000001766 X chromosome Anatomy 0.000 claims 1
- 201000010251 cutis laxa Diseases 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51447603P | 2003-10-27 | 2003-10-27 | |
| US60/514,476 | 2003-10-27 | ||
| PCT/US2004/035440 WO2005044251A2 (en) | 2003-10-27 | 2004-10-27 | Methods of lowering lipid levels in a mammal |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007509946A JP2007509946A (ja) | 2007-04-19 |
| JP2007509946A5 true JP2007509946A5 (enExample) | 2007-11-22 |
| JP4976851B2 JP4976851B2 (ja) | 2012-07-18 |
Family
ID=34572758
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006538169A Expired - Fee Related JP4976851B2 (ja) | 2003-10-27 | 2004-10-27 | 脂質レベルを哺乳動物において低下させる方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US7320988B2 (enExample) |
| EP (2) | EP1682114A2 (enExample) |
| JP (1) | JP4976851B2 (enExample) |
| AU (1) | AU2004287434B2 (enExample) |
| CA (1) | CA2543611A1 (enExample) |
| WO (1) | WO2005044251A2 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1682114A2 (en) * | 2003-10-27 | 2006-07-26 | City of Hope | Methods of lowering lipid levels in a mammal |
| WO2007044309A2 (en) * | 2005-10-05 | 2007-04-19 | Vasix Corporation | Device and method for inhibiting age complex formation |
| US8580854B2 (en) * | 2005-11-09 | 2013-11-12 | City Of Hope | Methods of suppression of rage gene expression and rage triggered inflammatory genes by selected age-inhibitors |
| US8124655B2 (en) * | 2007-06-15 | 2012-02-28 | City Of Hope | Use of LR-90 and LR-102 to overcome insulin resistance |
| US9808434B2 (en) | 2011-01-27 | 2017-11-07 | City Of Hope | Compound for treating cancer and diabetes |
| WO2012103523A2 (en) | 2011-01-27 | 2012-08-02 | Samuel Rahbar | Novel modulators of development of adipocyte and cancer cells |
| US11471497B1 (en) | 2019-03-13 | 2022-10-18 | David Gordon Bermudes | Copper chelation therapeutics |
| US20230048576A1 (en) * | 2019-03-19 | 2023-02-16 | City Of Hope | Compounds for the treatment of neuropathic pain |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US514476A (en) | 1894-02-13 | Minnow-bucket | ||
| WO1981002671A1 (en) | 1980-03-20 | 1981-10-01 | Ferring Farma Lab | Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease by oral administration |
| US5272176A (en) | 1984-03-19 | 1993-12-21 | The Rockefeller University | Advanced glycation inhibitors containing amino-benzoic acids and derivatives, and methods of use |
| US5100919A (en) | 1984-03-19 | 1992-03-31 | The Rockefeller University | Biguanides and derivatives thereof as inhibitors of advanced glycosylation of a target protein |
| US5700447A (en) * | 1992-05-21 | 1997-12-23 | The Picowder Institute For Medical Research | Methods and materials for the diagnosis and treatment of conditions such as stroke |
| DE3410927A1 (de) | 1984-03-24 | 1985-10-03 | Hoechst Ag, 6230 Frankfurt | Vollaromatische polyester, verfahren zu ihrer herstellung und entsprechende formkoerper |
| US4801610A (en) * | 1984-05-21 | 1989-01-31 | G. D. Searle & Co. | Phenolic ester derivatives as elastase inhibitors |
| US4603144A (en) * | 1984-08-16 | 1986-07-29 | G. D. Searle & Co. | Kojic acid ether-ester derivatives |
| US5268500A (en) | 1987-06-15 | 1993-12-07 | Montefiore Medical Center | Compound, composition and method for the reduction of lipids the modification of the affinity of hemoblogin for oxygen and the prevention of platelet aggregation |
| US4921997A (en) | 1988-06-15 | 1990-05-01 | Montefiore Medical Center | Method of synthesis and novel compounds for pharmaceutical uses |
| US5093367A (en) | 1988-06-15 | 1992-03-03 | Montefiore Medical Center | Method of synthesis and novel compounds for pharmaceutical uses |
| US5677330A (en) * | 1990-02-12 | 1997-10-14 | The Center For Innovative Technology | Medical uses of allosteric hemoglobin modifier compounds in patient care |
| US6046222A (en) | 1993-09-15 | 2000-04-04 | Warner-Lambert Company | Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
| US5833700A (en) | 1995-03-15 | 1998-11-10 | Ethicon Endo-Surgery, Inc. | Sterile occlusion fasteners and instrument and method for their placement |
| WO1995031192A1 (en) | 1994-05-16 | 1995-11-23 | Thomas Jefferson University | Method and use of agents to inhibit protein polymerization and methods of identifying these agents |
| US5661139A (en) | 1995-01-13 | 1997-08-26 | Alteon Inc. | Bis-(2-aryl) hydrazones |
| US5962651A (en) | 1995-01-27 | 1999-10-05 | Montefiore Medical Center | Modified hemoglobin and its use as a component of an artificial blood substitute |
| US5602277A (en) | 1995-03-30 | 1997-02-11 | Biocryst Pharmaceuticals, Inc. | Substituted benzene derivatives useful as neuraminidase inhibitors |
| US5667330A (en) | 1995-11-28 | 1997-09-16 | Case Corporation | Quick-connect mechanism for releasably retaining a power take-off shaft within an output shaft hub |
| US5716987A (en) | 1996-06-21 | 1998-02-10 | Bristol-Myers Squibb Company | Prophylactic and therapeutic treatment of skin sensitization and irritation |
| JP3864050B2 (ja) * | 1998-10-22 | 2006-12-27 | ユニヴァースティ オブ サウス カロライナ | 糖尿病合併症を治療または予防するための医薬組成物 |
| US6787566B2 (en) | 1999-04-05 | 2004-09-07 | City Of Hope | Breakers of advanced glycation endproducts |
| ATE260099T1 (de) * | 1999-04-05 | 2004-03-15 | Hope City | Neue hemmern von fortgeschrittenen glykosilierung-endprodukten |
| US6605642B2 (en) | 1999-04-05 | 2003-08-12 | City Of Hope | Inhibitors of formation of advanced glycation endproducts (AGES) |
| US7030133B2 (en) | 1999-04-05 | 2006-04-18 | City Of Hope | Inhibitors of formation of advanced glycation endproducts (AGEs) |
| US6589944B1 (en) * | 1999-04-05 | 2003-07-08 | City Of Hope | Breakers of advanced glycation endproducts |
| CA2371391A1 (en) | 1999-04-29 | 2000-11-09 | City Of Hope | Pentoxifylline, pioglitazone and metformin are inhibitors of formation of advanced glycation endproducts (age's) |
| JP2003516328A (ja) | 1999-12-13 | 2003-05-13 | プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ | 細胞死疾患および炎症を治療するための方法 |
| FR2836474B1 (fr) | 2002-02-22 | 2004-12-24 | Synt Em | Composes, compositions et methode pour le transport des molecules de cyclosporine a travers la barriere hemato-encephalique |
| EP1682114A2 (en) * | 2003-10-27 | 2006-07-26 | City of Hope | Methods of lowering lipid levels in a mammal |
-
2004
- 2004-10-27 EP EP04796420A patent/EP1682114A2/en not_active Ceased
- 2004-10-27 CA CA002543611A patent/CA2543611A1/en not_active Abandoned
- 2004-10-27 WO PCT/US2004/035440 patent/WO2005044251A2/en not_active Ceased
- 2004-10-27 EP EP20100183235 patent/EP2269601A1/en not_active Withdrawn
- 2004-10-27 US US10/974,028 patent/US7320988B2/en not_active Expired - Lifetime
- 2004-10-27 AU AU2004287434A patent/AU2004287434B2/en not_active Ceased
- 2004-10-27 JP JP2006538169A patent/JP4976851B2/ja not_active Expired - Fee Related
-
2007
- 2007-11-30 US US11/948,574 patent/US7652037B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2014231648B2 (en) | Substituted aromatic compounds and related method for the treatment of fibrosis | |
| JP2020073468A (ja) | 肝障害を処置するための１，３−ジフェニルプロパ−２−エン−１−オン誘導体の使用 | |
| TWI407955B (zh) | 高脂血症之預防及／或治療劑 | |
| JP2002543065A5 (enExample) | ||
| JP2010522710A5 (enExample) | ||
| JP2019531346A (ja) | 甲状腺関連副作用を低下させる方法 | |
| JP2009528275A5 (enExample) | ||
| US10363235B2 (en) | Compositions comprising 15-HEPE and methods of treating or preventing fibrosis using same | |
| JP2009513713A5 (enExample) | ||
| KR20190077131A (ko) | 선택적 s1p1 수용체 아고니스트를 포함하는 약학 조합물 | |
| BR0016135A (pt) | Forma de tamanho de partìcula reduzido, uso de uma substância, composição farmacêutica, métodos para o tratamento ou a profilaxia de condições associadas com reduzida sensibilidade à insulina e de deslipidemia, diabetes melito do tipo ii, hiperglicemia, hiperinsulinemia, hipertensão arterial e/ou obesidade abdominal e processo para a preparação de um composto | |
| JP2006524252A5 (enExample) | ||
| JP2014521641A5 (enExample) | ||
| JP2009541387A5 (enExample) | ||
| JP2007509946A5 (enExample) | ||
| JP5680412B2 (ja) | レオヌリンの使用およびその組成物 | |
| JP2005513014A5 (enExample) | ||
| JP2012518019A5 (enExample) | ||
| JP2001520994A5 (enExample) | ||
| JP2006514665A5 (enExample) | ||
| WO2006011397A1 (ja) | 糖尿病の予防または治療のための薬剤 | |
| JP2004538314A5 (enExample) | ||
| JP2009539877A5 (enExample) | ||
| JP2011520877A5 (enExample) | ||
| JP2013507438A5 (enExample) |